Advances in Pharmacological Research and Practice. Proceedings of the 4th Congress of the Hungarian Pharmacological Society, Budapest, 1985

Content: 
Inside Front Matter, Page II
Front Matter, Page III
Copyright, Page IV
PREFACE, Page V, J. Knoll, K. Kelemen
ON THE SCOPE AND MECHANIÓSMS OF LOCAL CONTROL OF NEUROTRANSMITTER SECRETION FROM INDIVIDUAL VARICOSITIES OF THE SYMPATHETIC NERVES OF THE GUINEA-PIG AND MOUSE VAS DEFERENS, Pages 3-12, L. STJÄRNE
THE TOPOGRAPHY OF CHOLINERGIC TRANSMISSION, Pages 13-18, O. KADLEC, I. ŠEFERNA, D. HERGERNRÖTHER, K. MAŠEK, E.S. VIZI, G.T. SOMOGYI
SUBTYPES OF MUSCARINE RECEPTORS IN THE GUINEA-PIG ILEUM, Pages 19-22, H. KILBINGER
PRESYNAPTIC ALPHA-2 ADRENOCEPTORS, Pages 23-28, E.S. VIZI, J. KAPOCSI, N. LUDVIG
POSTSYNAPTIC ALPHA-2 ADRENOCEPTORS AND CHEMICAL TRANSMISSION, Pages 29-41, P.B.M.W.M. TIMMERMANS
THE EFFECT OF NONDEPOLARIZING MUSCLE RELAXANTS ON TRANSMITTER RELEASE AT PERIPHERAL CHOLINERGIC RECEPTOR SITES, Pages 43-46, F.F. FOLDES, E.S. VIZI
SUBSENSITIVITY OF PRESYNAPTIC AND SUPERSENSITIVITY OF POSTSYNAPTIC DOPAMINERGIC RECEPTORS AS A RESULT OF REPEATED ADMINISTRATION OF ANTIDEPRESSANT DRUGS, Pages 47-55, J. MAJ, K. WEDZONY, G. SKUZA
MODULATION OF NEUROTRANSMITTER RECEPTORS AND DRUG RECOGNITION SITES BY REPEATED DOSES OF (-)DEPRENYL, Pages 57-65, G. ZSILLA, A.M. SZÉKELY, J. KNOLL
THE EFFECT OF ANTIMUSCARINIC DRUGS ON AGGRESSIVE BEHAVIOUR AND CONVULSIONS EVOKED BY CARBACHOL: UNITARY CONCEPT OR DIFFERENT SENSITIVITIES OF CENTRAL CHOLINOCEPTORS, Pages 67-77, D.B. BELESLIN, RANKA SAMRDŽIĆ, KSENIJA STEFANOVIĆ-DENIĆ
CHOLINESTERASE INHIBITORS AND CORTICOSTEROIDS INTERACT WITH GENERAL ANAESTHETICS BY ALTERING CENTRAL CHOLINERGIC MECHANISMS, Pages 79-82, R.S. LEEUWIN, J.K. VAN DER WAL, A. ZEEGERS
GABA RECEPTORS IN THE MYENTERIC PLEXUS FROM MORPHINE-TOLERANT GUINEA-PIGS, Pages 83-85, S. LUZZI, S. FRANCHI-MICHELI, M. CIUFFI, L. ZILLETTI
THE EFFECT OF 1-NORADRENALINE AND XYLAZINE ON THE RELEASE OF NORADRENALINE DURING K+-CHANNEL INHIBITION IS NOT MEDIATED VIA α2-ADRENOCEPTORS, Pages 87-90, I. ZIMÁNYI, E.S. VIZI
DESIGN AND SYNTHESIS OF 5H-2,3-BENZODIAZEPINES, Pages 91-97, T. LÁNG, J. KORÖSI, G. ZÓLYOMI, T. HÁMORI, P. BOTKA
MODULATION OF 3H-NORADRENALINE RELEASE FROM ISOLATED HUMAN CYSTIC ARTERY, Pages 99-104, J. KAPOCSI, E.S. VIZI
NEUROTRANSMISSION IN LARVAL AND PARASITIC LIFE: A STUDY ON SCHISTOSOMA MANSONI, Pages 105-107, N. ERCOLI, L. HIDALGO, M. ARISPE
GABA-ERGIC MECHANISMS IN ANTICONVULSIVE ACTIVITY OF HYDROXYLAMINE AND HYDRAZINE DERIVATIVES OF BARBITURIC ACID, Pages 109-111, D.P. GETOVA, V.P. GEORGIEV
EFFECT OF DRUGS CLASSIFIED AS α2-ADRENOCEPTOR AGONISTS AND ANTAGONISTS ON THE ELECTROSHOCK-INDUCED SEIZURES IN MICE, Pages 113-115, N. LUDVIG, L. GYÖRGY, E.S. VIZI
THE THEORY OF MULTIPLE CHEMICAL SIGNALS IN SYNAPTIC TRANSMISSION AS IT EMERGES FROM GABA/BENZODIAZEPINE INTERACTION, Pages 119-129, E. COSTA, P. FERRERO, A. GUIDOTTI, R. SANTI
PHARMACOLOGICAL CHARACTERIZATION OF GABA AND BENZODIAZEPINE BINDING SITES LOCALIZED IN THE NON-JUNCTIONAL SYNAPTIC REGION, Pages 131-136, J. KARDOS, F. HAJÓS, M. SIMONYI
INTERACTION OF DIFFERENT COMPOUNDS, HAVING ATYPICAL ANXIOLYTIC PROPERTIES WITH GABA-BENZODIAZEPINE RECEPTOR COMPLEX, Pages 137-144, A.V. VALDMAN, V.V. ROSHANETS, N.D. DANTCHEV, K.M. MALIN, K.K. CHABRA, R.A. ACKHUNDOV
GABA CONTRIBUTION TO THE EFFECT OF NARCOTIC ANALGETICS ON THE SPINAL CORD AND CEREBRAL CORTEX, Pages 145-156, D.A. KHARKEVICH, V.P. FISENKO, S.A. KASPAROV
ALLOSTERIC INTERACTIONS AT CONVULSANT SITES COUPLED TO GABA RECEPTOR IONOPHORES, Pages 157-160, M.K. TICKU, G. MAKSAY
THE EFFECT OF 2,3-BENZODIAZEPINES ON THE BENZODIAZEPINE-GABA-PICROTOXIN/BARBITURATE-CI-ION CHANNEL COMPLEX, Pages 161-163, A. KENESSEY, P. PÁLDI-HARIS, L. GRÁF, T. LÁNG, J. KORÖSI
ACTH AND RELATED PEPTIDES AS PSYCHOACTIVE AND NEUROACTIVE DRUGS, Pages 165-175, D. DE WIED
PHARMACOLOGICAL ACTIONS OF MODIFIED CASOMORPHINS, Pages 177-182, H. MATTHIES, GISELA GRECKSCH, CHRISTINE RAUCA, HEIDE-LINDE RÜTHRICH, CHRISTINA SCHWEIGERT, A. BARTH, BIANKA HARTRODT, K. NEUBERT, H. STARK
MURAMYL PEPTIDES: IMMUNOMODULATORS AND CENTRALLY ACTING DRUGS, Pages 183-188, K. MAŠEK
SPONTANEOUS RELEASE OF HISTAMINE FROM MAST CELLS, Pages 189-193, F. ERJAVEC
ADENYL CYCLASE (AC) AND GUANYL CYCLASE (GC)-COUPLED HISTAMINE (HA) RECEPTORS IN THE BRAIN, Pages 195-202, Z. HUSZTI, K. MAGYAR
POSSIBLE INVOLVEMENT OF THE SPINAL DYNORPHINERGIC SYSTEM IN NOCICEPTIVE MECHANISMS, Pages 205-214, S. FERRI, S. CANDELETTI, E. CAVICCHINI, P. ROMUALDI, E. SPERONI, S. SPAMPINATO
AFFINITY LABELING OF OPIOID RECEPTOR SUBUNITS BY 3H-D-ALA2-LEU5-ENKEPHALIN CHLOROMETHYL KETONE, Pages 215-219, M. SZÜCS, J. SIMON, M. BELCHEVA, S. BENYHE, A. BORSODI, J. HEPP, M. WOLLEMANN, K. MEDZIHRADSZKY, G. TÓTH
CHARACTERISTICS OF OPIATE A AND B RECEPTORS STIMULATED OR INHIBITED BY INTRATHECALLY ADMINISTERED OPIATES IN THE RAT, Pages 221-230, SUSANNA FüRST, J. KNOLL
PHYSICAL SEPARATION OF κ-OPIOID BINDING SITE FROM FROG BRAIN, Pages 231-233, J. SIMON, S. BENYHE, A. BORSODI, M. SZÜCS, M. WOLLEMANN, G. TÓTH
TRANSGANGLIONIC EFFECT OF BASIC PEPTIDES ON THE PRIMARY NOCICEPTIVE ANALYZER, Pages 235-242, B. CSILLIK, J. TAJTI, E. KNYIHÁR-CSILLIK, K. KOVÁCS, B. PENKE, J. SZILÁRD, A. SZÜCS
OPIOID EFFECTS IN HUMAN GRANULOCYTES (PMN), Pages 243-250, EIKE G. FISCHER, NORA E. FALKE
DISPLACEMENT STUDIES AMONG DIFFERENT OPIOID AGONISTS, Pages 251-254, A. TAGLIAMONTE, P. DEVOTO, M.G. DE MONTIS
RELATIONSHIPS BETWEEN THE SUGGESTED OPIOID RECEPTORS, Pages 255-264, T. FRIEDMANN, J. KNOLL
COMPARISON OF THE EFFECT OF LOW DOSE MORPHINE (M) AND FENTANYL (F) ON CATECHOLAMINES DURING SCOLIOSIS SURGERY, Pages 265-268, A.H. ANTON, K.S. PATHAK, C.A. SUTHEIMER
BEHAVIORALLY ACTIVE OXYTOCIN FRAGMENTS DIMINISH INTRAVENOUS SELF-ADMINISTRATION OF HEROIN IN HEROIN-TOLERANT RATS, Pages 269-272, G.L. KOVÁCS, J.M. VAN REE
INFLUENCE OF OXYTOCIN AND AN ANALOG ANTAGONIST OF OXYTOCIN ON THE DEVELOPMENT OF ACUTE MORPHINE TOLERANCE IN MICE, Pages 273-276, Z. SARNYAI, G.L. KOVÁCS, G. SZABÓ, G. TELEGDY, K. JOST, T. BARTH
GLUCOCORTICOID-INDUCED CHANGES IN CENTRAL OPIATE AND ADRENERGIC MECHANISMS, Pages 277-284, M.I.K. FEKETE, B. KANYICSKA, T. SZENTENDREI
INCREASED POTENCY OF NALOXONE AGAINST MORPHINE IN MICE PRETREATED WITH D-MET2, PRO5-ENKEPHALINAMIDE (EA): A DEMONSTRATION OF ACUTE CROSS-SENSITIZATION, Pages 285-291, ILDIKÓ ÁRKI, G. MENCZELESZ, J.I. SZÉKELY
PHARMACOKINETIC—PHARMACODYNAMIC RELATIONSHIPS FOR MULTIPLE RECEPTOR INTERACTING DRUGS, Pages 295-308, L.K. PAALZOW
THE EFFECT OF NOVEL PSYCHOTROPIC DRUGS ON RAT BRAIN DOPAMINE- AND ALPHA-ADRENERGIC RECEPTOR BINDING IN VITRO, Pages 309-312, K.I. GYÜRE, T. SZENTENDREI, M.I.K. FEKETE, A.Z. RÓNAI
STRESS, ADRENERGIC AGENTS AND INFECTION, Pages 313-319, H. RAŠKOVÁ, L. ČELEDA, Z. URBANOVÁ, J. VANĚČEK, A. KUBIČEK
CLINICAL PHARMACOLOGY OF MABUTEROL; A NEW BETA-2-SYMPATHOMIMETIC DRUG WITH BRONCHODILATING EFFECTS, Pages 321-324, Z. VOTAVA, O. NOVOTNÝ, M. MIHOKOVÁ
EFFECT OF DENERVATION ON THE MOVEMENT OF TAURINE IN SKELETAL MUSCLE, Pages 325-329, H. IWATA, A. BABA, B.K. KIM
SELECTIVE α1 RECEPTOR BLOCKER PRAZOSIN AND LIVER FUNCTIONS, Pages 331-334, JUDITH GERGELY
AUTORADIOGRAPHIC DRUG DISTRIBUTION STUDIES, Pages 351-360, S. ULLBERG
PHARMACOKINETIC ASPECTS OF THE MODE OF ACTION OF EGYT-475, A NEW ANTIDEPRESSIVE AGENT, Pages 361-367, K. MAGYAR
MODEL-INDEPENDENT (SYSTEMIC) APPROACH IN PHARMACOKINETICS, Pages 369-376, V.K. PIOTROVSKII
PHARMACOKINETICS, METABOLISM AND ELIMINATION AND THEIR RELATION TO THE EFFECTS AND TOXICITY OF SELECTED DRUGS AND CHEMICALS, Pages 377-385, I. GUT
EPIGENETIC IMPRINTING OF DRUG METABOLISM, Pages 387-397, W. KLINGER, F. JAHN
THE ROLE OF MELANIN BINDING IN THE METABOLISM AND PHARMACOKINETICS OF DRUGS, Pages 399-405, T. SZÜTS, G. BÁTHORY, K. MAGYAR
ON THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE OF THE NOVEL ANTIDEPRESSIVE, NOMIFENSINE, Pages 407-411, E. SYVÄLAHTI, R. LINDBERG, M. SCHEININ, J. HIETALA, K. PIHLAJAMÄKI, H. SCHEININ
THE PHARMACOKINETICS OF VINPOCETINE IN PATIENTS WITH IMPAIRED LIVER FUNCTION, Pages 413-417, P. MISKOLCZI, L. VERECZKEY, L. SZPORNY, L. SZALAY, C.S. GÖNDÖCS, J. FEHÉR, J. VISI, M. SIMONYI
THE ABSORPTION, TISSUE DISTRIBUTION AND ELIMINATION OF RGH-2957 (YUTACR) IN RATS, Pages 419-422, M. KAPÁS, L. VERECZKEY
CHANGES IN DRUG METABOLISM BY STEROID TREATMENTS OF FEMALE RATS, Pages 423-427, G. FEUER, C.J. DI FONZO, S.I. GRACON, M.S.I. DHAMI, J.M. STURGESS, F.A. DE LA IGLESIA
INFLUENCE OF ENZYME INDUCTION AND PARACETAMOL POISONING ON AMINOANTIPYRINE BLOOD LEVELS IN MICE, Pages 429-433, M. MIKOV
BIOAVAILABILITY OF VARIOUS NIFEDIPINE DOSING FORMS IN BEAGLE DOGS, Pages 435-440, E. PALKA, P. VODOPIVEC, M. JAPELJ
PHARMACOKINETIC ASPECTS OF INTERACTION BETWEEN THIOPENTAL AND ANTIDEPRESSANT DRUGS, Pages 441-445, M. MELZACKA, A. ADAMUS, W. DANIEL
XANTHOGENATES: SOME MECHANISMS OF CYTOCHROME-P-450 INHIBITION, Pages 447-451, S. YANEV, T.S. STOYTCHEV
1-[3-TRIFLUOROMETHYL-PHENYL]-1-[5,6-DIHYDROXY-CYCLOHEXA-DIENE-2-YL] PROPANE-1-OL, A NEW METABOLITE OF FLUMECINOL IN HUMANS, Pages 453-457, I. KLEBOVICH, L. VERECZKEY, M. MÁK, J. TAMÁS
TOXINS AND PHARMACOKINETICS OF RIFAMPICIN, Pages 459-464, J. VANĚČEK, J. LAVICKÝ, Z. URBANOVÁ, H. RAŠKOVÁ
ANTIPYRINE-CLEARANCE AND PARACETAMOL METABOLISM IN DIABETICS, Pages 465-468, J.R. WEISER, J. PETERSEN, D. DENNIN, R. PENTZ, C.-P. SIEGERS
DRUG METABOLIZING PROCESSES IN EXPERIMENTAL HYPOTHYREOSIS AND HYPERTHYROXINEMIA IN RATS, Pages 469-473, W. SIEGMUND, G. FRANKE, A. SCHERBER, G. HÜBNER, R. HAMPEL
MECILLINAM — PHARMACOKINETIC AND CLINICAL STUDY, Pages 475-480, H. ADAMSKA-DYNIEWSKA, W. TKACZEWSKI, Z. PIELOCH, A. DENYS, E. MAŁAFIEJ
PHARMACOKINETICS OF SYNTROPIUM IN MAN STUDIED BY USING A RADIORECEPTOR ASSAY, Pages 481-486, G. SEGRE, C. BECHERUCCI
COMPRISON OF MONOOXYGENASE ACTIBITIES, METAPOLITE PATTERNS AND DNA ADDUCTS IN VARIOUS MICROSOME-MEDIATED BENZO(a)PYRENE METABOLIZING SYSTEMS, Pages 487-490, B. SCHOKET, I. VINCZE, P. WENIGER, H. ALTMANN
DISAPPEARANCE OF SEX DIFFERENCE IN PENTOBARBITONE SLEEPING TIME OF MICE HOUSED IN CAGES WITH WIRE GRID FLOOR, Pages 491-494, K.H.O. PELKONEN, K. HAASIO
INVESTIGATION ON TIME-DEPENDENT PHARMACOKINETICS OF ADRIAMYCIN IN PATIENTS WITH DIFFERING LIVER STATUS, Pages 495-498, R. PREISS, R. SOHR, H. HÜLLER, M. MATTHIAS, B. BROCKMANN
INFLUENCE OF ACETYLATOR PHENOTYPE ON METABOLISM OF 5-AMINO-SALICYLIC ACID, Pages 499-501, P. HÖGLUND, L.-G. NILSSON, O. PAULSEN
STUDIES ON THE MELANIN AFFINITY OF p-BROMO-METHYL-AMPHETAMINE (V-111) AND OTHER AMPHETAMINE DERIVATIVES, Pages 503-506, G. BÁTHORY, K. MAGYAR, T. SZUTS
LIST OF CONTRIBUTORS, Pages 335-342
SUBJECT INDEX, Pages 343-347
LIST OF CONTRIBUTORS, Pages 507-510
SUBJECT INDEX, Pages 511-514